//-->   Home     News     Mutual Funds     Insurance     Markets      IPO       Forum       Contact Us

Markets Markets News Trading Calls BSE Indices NSE Indices Bulk Deals Weekly Gainers Weekly Losers BSE Replica BSE Announcements NSE Announcements    News All News    Mutual Fund MF News Recent Dividends Top Equity Funds Top Balanced Funds Mutual Fund FAQ    IPO IPO News Issues Open Now IPO Allotment Status    Insurance Life Insurance   Insurance News Look at assured sum when choosing life insurance products All you need to know about car insurance The Term Plan: Features and riders Fine print of claiming deduction on life insurance premium

Aditya Exports Ltd Business Today Ranbaxy stock tanks on court filing in US Livemint Shares of India's largest drug maker Ranbaxy Laboratories Ltd fell the most among blue-chip stocks on the Bombay Stock Exchange on Friday as investors fretted about the cost of a proposed settlement with the US Food and Drug Administration (FDA) ... Ranbaxy Falls Most Since March on Settlement Costs: Mumbai MoverBusinessWeek all 150 news articles » News Roundup: Blackstone Pledges Gokaldas Stake VC Circle BY TEAM VCC Blackstone Pledges Gokaldas Stake - Private equity giant Blackstone has pledged its entire equity stake in Gokaldas Exports, the country's largest apparel exporter, to raise funds marking a rare instance in which a PE fund has resorted to ... and more » Moneycontrol.com Sell Usha Martin; target of Rs 22: Aditya Birla Money Moneycontrol.com Aditya Birla Money is bearish on Usha Martin and has recommended sell rating on the stock with a target of Rs 22 in its February 2, 2012 research report. "Usha Martin Ltd. (UML) Q3FY12 results were below our expectations on account of (1) ... and more » Bloomberg Ranbaxy Falls Most Since March on Proposed Settlement Costs: Mumbai Mover Bloomberg Ranbaxy Laboratories Ltd. (RBXY), India's biggest drugmaker, slumped the most in ten months in Mumbai trading because of costs of a proposed settlement with US authorities over manufacturing violations. Ranbaxy declined 6.5 percent to 443.90 rupees, ... and more » Industry demands growth boosters Business Standard The big guns of India Inc skipped the pre-Budget interaction with finance minister Pranab Mukherjee on Friday, even as other industry representatives suggested boosting economic activities, which have been hit hard by external headwinds and the Reserve ... and more » Economists for diesel decontrol in budget Chandigarh Tribune Among the economists who attended the meeting included Surjit Bhalla, Nitin Desai, Rajiv Kumar of FICCI, Sudipto Mundle of NIPFP, Bharat Ramaswamy of ISI, Delhi, Ajit Ranade of the Aditya Birla group and M. Govind Rao of NIPFP. and more » Luthra assists Tata to bring Starbucks Coffee to India; Amarchand advises ... Bar & Bench The 50:50 joint venture, named TATA Starbucks Limited, will own and operate Starbucks cafes which will be branded as Starbucks Coffee “A Tata Alliance.” Luthra & Luthra Law Offices advised Tata with a team led by Managing Partner Rajiv Luthra and ... and more » Moneycontrol.com Forex and the RBI: For a few dollars more Moneycontrol.com The Nuclear Power Corporation of India Limited (NPCIL), when it buys reactor components, settles bills partly in dollars and partly in rupees. These days it has been trying to convince component suppliers like Areva to take the payment entirely in ... and more » Outlook It Ain't Over Yet Outlook While export-focused rupee beneficiaries are expected to do well, analysts believe rising input costs and limited pricing power might lead to margin contraction across the board. Tirthankar Patnaik of Religare Institutional Research feels Sensex ...

//-->

List 1   |   List 2   |   List 3   |   List 4   |   List 5   |   List 6   |   List 7   |   List 8   |   List 9   |   List 10   |   List 11   |   List 12   |   List 13

	DISCLAIMER: The views and investment tips expressed on marketsbull.com are on the basics of market study. marketsbull.com is not responsible for any losses that could occur due to this information, and advises users to check with certified experts before taking any investment decision. marketsbull.com does not guarantee the accuracy, adequacy or completeness...